Transferring Your Hormone or GLP-1 Care to a Local Clinic

A growing share of the people who book a first visit with me are not new to treatment at all. They are already on testosterone, or already on a GLP-1 like semaglutide or tirzepatide, and what they actually want is to move that care somewhere local — somewhere with an exam room, in-person labs, and a provider they can sit across from. Some have relocated to the Columbus or middle Georgia area. Some started on a mail-order or app-based model and have decided they want closer monitoring. And some have had their supply interrupted and need to re-establish care before a gap turns into a problem.

Transferring established care is a different task than starting from scratch, and it is worth understanding how a responsible clinic handles it before you book. This article walks through what to bring, why a careful provider re-checks your baseline instead of simply refilling what you were on, the specific risk created when a compounding source is discontinued, and how a transfer visit differs from a brand-new consultation. The goal is continuity without cutting the corners that make continuity safe.

Why people move their hormone or GLP-1 care to a local clinic

The reasons cluster into a few patterns. The most common is simple geography: someone moved to the area, or realized the closest clinic doing this kind of work is here, and driving to an office beats managing everything through a screen. Others started remotely because it was the fastest way to begin, and over time decided that ongoing treatment — especially something like testosterone or a GLP-1 that changes real physiology — deserves hands-on monitoring rather than a quarterly questionnaire.

A third group is reacting to a disruption. A platform changed its formulary, a compounding pharmacy stopped producing the preparation they were on, or the person simply wants labs drawn and read by someone who will look at the whole picture rather than a single number. Whatever the trigger, the underlying instinct is sound: treatment that alters hormones or metabolism benefits from a provider who knows your history, examines you, and adjusts based on data. That is the case I make for in-person weight-loss monitoring and for hands-on men's testosterone therapy generally, and it is doubly true when you are handing an existing regimen to a new set of hands.

What to bring to a transfer visit

The single biggest factor in how smoothly a transfer goes is how complete your records are. A transfer with good documentation can move quickly to a confirmed plan. A transfer with nothing but a memory of "I think I'm on the higher dose" has to start slower, because I will not build on a foundation I cannot see. Bring what you can of the following:

• Your labs — both recent and baseline. The most useful pair is the panel from before you started treatment and your most recent panel on treatment. Together they tell me where you began and how your body has responded.
• Your current prescription details. The exact drug, the dose, the formulation (brand versus compounded, and if compounded, what is in it), the pharmacy, and when you started.
• Your titration history. How you got to the current dose — what you started at, how it was increased, and how you tolerated each step.
• A full medication and supplement list. Everything, including over-the-counter products and anything taken intermittently, because interactions and lab interference are real.
• Relevant history and imaging. Prior side effects, any relevant scans or specialist notes, and for testosterone patients, any prostate or blood-count history.
• A photo ID and your pharmacy information, so we can coordinate cleanly once a plan is set.

If some of this is missing, come anyway — we can often reconstruct it or redraw labs — but understand that gaps in the record translate directly into a more cautious first visit. Requesting your records from a prior provider or platform before you come is the highest-yield thing you can do to make the handoff efficient. The general shape of a first visit, including what the history and exam cover, is laid out in what to expect at your first hormone consultation; a transfer follows the same structure with more emphasis on your existing regimen.

Why we re-baseline instead of continuing a dose blind

Here is the part that occasionally surprises people, so I want to explain the reasoning rather than just assert it. When a new provider takes over your treatment, that provider becomes accountable for it. Continuing a dose I have not verified — with labs I have not seen and an exam I have not done — means being responsible for a plan I cannot actually vouch for. That is not caution for its own sake, and it is not a way to generate extra visits. It is the difference between a clinic that owns your care and a refill window.

Re-baselining does not mean starting over or discarding your progress. In most cases it confirms that what you are on is appropriate and lets us continue with confidence, sometimes exactly as-is. In some cases it catches something worth adjusting — a safety marker drifting in the wrong direction, a dose that made sense at the start but no longer fits, or a lab that was never checked in the first place. Either way, you end up with a plan grounded in current data rather than an inherited assumption. Individual response varies, and the only way to know where you actually stand is to look.

What re-baselining looks like for testosterone therapy

For a testosterone transfer, the confirmation labs matter for both effectiveness and safety. I want to see total and free testosterone to know where your levels actually sit on your current protocol, because the number that matters clinically is not always the one people quote — the distinction between total and free is worth understanding, and I walk through it in free testosterone versus total testosterone.

Beyond the level itself, testosterone therapy carries monitoring obligations that a responsible provider does not skip: hematocrit and a complete blood count, because testosterone can thicken the blood over time; estradiol, because it moves with testosterone and shapes how you feel; a lipid panel; and age-appropriate prostate monitoring. If those have not been checked recently, checking them is not bureaucracy — it is the standard of care that makes ongoing testosterone treatment safe to continue. The point of the transfer visit is to confirm you are optimized and protected, then keep you there.

What re-baselining looks like for GLP-1 therapy

A GLP-1 transfer has its own checklist. I want to understand your weight trajectory — where you started, how you have responded, and whether the curve is still moving or has flattened, since a plateau changes the conversation. I confirm the metabolic picture with current labs, and I screen for the contraindications that apply to this class regardless of who prescribed it first: a personal or family history of medullary thyroid carcinoma or MEN2, prior pancreatitis, and active gallbladder disease among them.

I also want to know how you have tolerated the medication and whether muscle loss is being accounted for, because rapid weight loss on a GLP-1 costs lean mass when protein and resistance training are not deliberately protected. Continuity here is not just "keep the injection going." It is confirming the drug is still the right tool, at the right dose, inside a plan that protects your muscle and sets up a durable result — the same logic behind the maintenance phase that avoids the rebound. A transfer is a good moment to make sure that framework is actually in place rather than assumed.

The compounding-source gap — the risk worth planning around

One specific scenario deserves its own section, because it is the one most likely to leave someone stranded. A large share of the compounded semaglutide and tirzepatide that flooded the market came through telehealth platforms during the drug shortage. When the FDA removed those drugs from the shortage list, it changed what compounding pharmacies may routinely produce — I covered exactly what shifted and why in compounded versus brand-name GLP-1 and what the FDA update means, and I will not repeat all of it here.

The practical fallout is a supply gap. People who were reliably receiving a compounded preparation have found it discontinued, sometimes with little warning, and abruptly stopping a GLP-1 is not a neutral event: appetite returns, and the weight often follows if there is no plan to catch it. The wrong response to that gap is to stretch a dwindling supply, chase an unverified online source, or ration doses on your own. The right response is to re-establish care before you run out, so a provider can either transition you to brand-name product or, where there is a genuine documented clinical reason, an individualized compounded preparation through a verified pharmacy partner. If this is your situation, bring the details of your current vial — the more we know about exactly what you were on, the cleaner the transition. This is a service-model problem, not a verdict on any particular provider, and it is very solvable when you do not wait until the last dose.

How a transfer visit differs from a brand-new consultation

It helps to know what the visit will actually feel like, because it is genuinely different from a first-time evaluation. A brand-new consultation starts from symptoms — someone comes in tired, or heavier than they want to be, or not feeling like themselves — and the work is to build a hypothesis and test it. A transfer starts from a regimen you are already on and, usually, already tolerating. The diagnostic question is largely settled. The work is verification and continuity: confirming the treatment is right, safe, and well-dosed, then refining it.

In practice that means the history focuses on your treatment story rather than working up a mystery, the exam and labs are oriented toward confirming and protecting an existing plan, and — when your records are complete — the path to a confirmed regimen can be shorter than a first-time workup. It is still a real clinical visit with a real evaluation behind it. It is simply pointed at a different question. That difference is also why continuity of the relationship matters so much over time, a theme I come back to in why patients travel for hormone care — the value compounds when one provider follows your numbers across years.

Continuity across our Columbus and Warner Robins locations

For patients in the region, the two-location setup is built for exactly this kind of ongoing care. The Columbus clinic and the Warner Robins clinic run the same clinical protocols, the same pharmacy partners, and the same lab partners, and Travis Woodley rotates between both on a published schedule. You can transfer your care in at whichever location is convenient and stay continuous across both if your work or life moves you between them.

The online booking portal handles both locations on a single calendar, so you are not choosing a clinic so much as choosing a time and place for a practice that operates as one. For someone coming off a remote model, the appeal is straightforward: a consistent provider, a consistent protocol, and two physical places you can actually walk into when a lab needs drawing or a dose needs a conversation.

What ongoing care looks like after the transfer

Once the transfer visit confirms your plan, the rhythm settles into something predictable. We re-baseline at the start, adjust if the data calls for it, and then follow up on a schedule matched to your treatment. For hormone therapy, the reassessment at roughly three months is the checkpoint that tells us whether the plan is working and what to fine-tune, which is why the three-month reassessment matters rather than being optional. For GLP-1 therapy, ongoing visits watch the weight trajectory, protect lean mass, and plan deliberately for the maintenance phase instead of letting it default.

This is also where in-person care earns its keep over a remote model. Labs get drawn and interpreted, safety markers get watched, and the plan flexes based on how your body is actually responding rather than a self-reported check-in. The medical weight loss program and hormone optimization both run on that loop of measure, adjust, and re-measure — and a transfer simply plugs your existing treatment into it.

The concrete next step

If you are on testosterone or a GLP-1 and want that care handled locally, the most useful thing you can do before you book is gather your records — recent labs, baseline labs if you have them, your exact current prescription, and your titration history. Then book a transfer visit at the Columbus clinic or the Warner Robins clinic, or through the online booking portal, and tell the intake you are transferring existing treatment so we set aside the right kind of visit.

Come expecting a conversation about confirming and protecting a plan you are already on, not a sales pitch for a new one. Visits, labs, and medications here are cash-pay, and we talk through realistic costs openly, with financing options available for those who want them. If you are not sure which consultation type fits, the comprehensive lab work pathway will route you. The aim of a good transfer is simple: no gap, no blind dosing, and a provider who actually knows your numbers going forward.

*Information in this article is educational and does not constitute medical advice. Decisions to continue, adjust, or stop any medication require a consultation and appropriate lab work. Individual results vary.*

TW

Travis Woodley

MSN, RN, CRNP — Platinum Biote Provider — Founder, Revitalize

Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.

Book a ConsultationCall ColumbusCall Warner Robins

About Travis →More articles →Rebuild Institute →